8 patents
Utility
Gene therapies for lysosomal disorders
7 Nov 23
The disclosure relates, in some aspects, to compositions and methods for treatment of diseases associated with aberrant lysosomal function, for example Parkinson's disease and Gaucher disease.
Asa Abeliovich, Laura Heckman, Herve Rhinn
Filed: 3 Oct 18
Utility
Gene therapies for lysosomal disorders
31 Oct 23
The disclosure relates, in some aspects, to compositions and methods for treatment of diseases associated with aberrant lysosomal function, for example Parkinson's disease and Gaucher disease.
Asa Abeliovich, Laura Heckman, Herve Rhinn
Filed: 3 Oct 18
Utility
Gene therapies for lysosomal disorders
30 May 23
The disclosure relates, in some aspects, to compositions and methods for treatment of diseases associated with aberrant lysosomal function, for example Parkinson's disease (PD) and Gaucher disease.
Asa Abeliovich, Laura Heckman, Herve Rhinn
Filed: 6 Apr 20
Utility
Gene therapies for lysosomal disorders
23 May 23
The disclosure relates, in some aspects, to compositions and methods for treatment of diseases associated with aberrant lysosomal function, for example Parkinson's disease (PD) and Gaucher disease.
Asa Abeliovich, Laura Heckman, Herve Rhinn
Filed: 18 Jun 20
Utility
Gene therapies for lysosomal disorders
28 Mar 23
The disclosure relates, in some aspects, to compositions and methods for treatment of diseases associated with aberrant lysosomal function, for example Parkinson's disease (PD) and Gaucher disease.
Asa Abeliovich, Laura Heckman, Herve Rhinn
Filed: 6 Apr 20
Utility
Gene therapies for lysosomal disorders
13 Jul 21
The disclosure relates, in some aspects, to compositions and methods for treatment of diseases associated with aberrant lysosomal function, for example Parkinson's disease and Gaucher disease.
Asa Abeliovich, Laura Heckman, Herve Rhinn
Filed: 17 Sep 20
Utility
Gene therapies for lysosomal disorders
16 Nov 20
The disclosure relates, in some aspects, to compositions and methods for treatment of diseases associated with aberrant lysosomal function, for example Parkinson's disease and Gaucher disease.
Asa Abeliovich, Laura Heckman, Herve Rhinn
Filed: 19 Nov 19
Utility
Gene therapies for lysosomal disorders
22 Jun 20
The disclosure relates, in some aspects, to compositions and methods for treatment of diseases associated with aberrant lysosomal function, for example Parkinson's disease (PD) and Gaucher disease.
Asa Abeliovich, Laura Heckman, Herve Rhinn
Filed: 20 Nov 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first